One shot to smooth scars? new trial begins
NCT ID NCT07474467
First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 2 times
Summary
This study tests a single injection of TRTP-101, a biological treatment, to see if it safely improves atrophic scars (like acne scars). Thirty-one adults will receive the injection on one side of their face and a placebo on the other, with neither they nor their doctors knowing which is which. The goal is to measure scar improvement and any side effects over several months.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- TRTP-101 (a biological injection)
- What this could lead to
- If it works, this could offer a new, one-time treatment to reduce the appearance of atrophic scars.
- What could go wrong
- This is an early, small trial (31 people) testing safety and effectiveness. The treatment may not work better than placebo, and there is a risk of side effects like skin reactions.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ATROPHIC SCAR are added.
By submitting, you agree to our Terms of use
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Samsung Medical Center
Seoul, South Korea
More trials for these conditions
Other studies related to the condition(s) this trial covers.